[HTML][HTML] Treatment options for paediatric anaplastic large cell lymphoma (ALCL): current standard and beyond
N Prokoph, H Larose, MS Lim, GAA Burke, SD Turner - Cancers, 2018 - mdpi.com
Anaplastic Lymphoma Kinase (ALK)-positive Anaplastic Large Cell Lymphoma (ALCL),
remains one of the most curable cancers in the paediatric setting; multi-agent chemotherapy …
remains one of the most curable cancers in the paediatric setting; multi-agent chemotherapy …
Rare non‐Hodgkin lymphoma of childhood and adolescence: a consensus diagnostic and therapeutic approach to pediatric‐type follicular lymphoma, marginal zone …
…, A Beishuizen, GAA Burke… - Pediatric Blood & …, 2020 - Wiley Online Library
Pediatric‐type follicular (PTFL), marginal zone (MZL), and peripheral T‐cell lymphoma (PTCL)
account each for <2% of childhood non‐Hodgkin lymphoma. We present clinical and …
account each for <2% of childhood non‐Hodgkin lymphoma. We present clinical and …
[HTML][HTML] Rituximab for high-risk, mature B-cell non-Hodgkin's lymphoma in children
…, A Aupérin, M Pillon, GAA Burke… - … England Journal of …, 2020 - Mass Medical Soc
Background Rituximab added to chemotherapy prolongs survival among adults with B-cell
cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin’…
cancer. Data on its efficacy and safety in children with high-grade, mature B-cell non-Hodgkin’…
Embryonal precursors of Wilms tumor
…, G Barone, J Anderson, M Jorgensen, GAA Burke… - Science, 2019 - science.org
Adult cancers often arise from premalignant clonal expansions. Whether the same is true of
childhood tumors has been unclear. To investigate whether Wilms tumor (nephroblastoma; a …
childhood tumors has been unclear. To investigate whether Wilms tumor (nephroblastoma; a …
The clinical relevance of detection of minimal residual disease in childhood acute lymphoblastic leukaemia
J Moppett, GAA Burke, CG Steward, A Oakhill… - Journal of clinical …, 2003 - jcp.bmj.com
Risk directed treatment forms a central component of modern protocols for childhood acute
lymphoblastic leukaemia (ALL). A review of recent studies of minimal residual disease (MRD) …
lymphoblastic leukaemia (ALL). A review of recent studies of minimal residual disease (MRD) …
[HTML][HTML] Anaplastic large cell lymphoma arises in thymocytes and requires transient TCR expression for thymic egress
…, L Lamant, A Trinquand, CE Hook, GAA Burke… - Nature …, 2016 - nature.com
Anaplastic large cell lymphoma (ALCL) is a peripheral T-cell lymphoma presenting mostly in
children and young adults. The natural progression of this disease is largely unknown as is …
children and young adults. The natural progression of this disease is largely unknown as is …
[HTML][HTML] Whole exome sequencing reveals NOTCH1 mutations in anaplastic large cell lymphoma and points to Notch both as a key pathway and a potential …
…, TL Blundell, W Klapper, O Merkel, GAA Burke… - …, 2021 - ncbi.nlm.nih.gov
Patients diagnosed with anaplastic large cell lymphoma (ALCL) are still treated with toxic
multi-agent chemotherapy and as many as 25-50% of patients relapse. To understand disease …
multi-agent chemotherapy and as many as 25-50% of patients relapse. To understand disease …
IL10RA modulates crizotinib sensitivity in NPM1-ALK+ anaplastic large cell lymphoma
…, C Gambacorti-Passerini, GAA Burke… - Blood, The Journal …, 2020 - ashpublications.org
Anaplastic large cell lymphoma (ALCL) is a T-cell malignancy predominantly driven by a
hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, …
hyperactive anaplastic lymphoma kinase (ALK) fusion protein. ALK inhibitors, such as crizotinib, …
[PDF][PDF] Sequential inverse dysregulation of the RNA helicases DDX3X and DDX3Y facilitates MYC-driven lymphomagenesis
DDX3X is a ubiquitously expressed RNA helicase involved in multiple stages of RNA
biogenesis. DDX3X is frequently mutated in Burkitt lymphoma, but the functional basis for this is …
biogenesis. DDX3X is frequently mutated in Burkitt lymphoma, but the functional basis for this is …
[HTML][HTML] Genomic abnormalities of TP53 define distinct risk groups of paediatric B-cell non-Hodgkin lymphoma
…, KM Wood, D Televantou, SD Turner, GAA Burke… - Leukemia, 2022 - nature.com
Children with B-cell non-Hodgkin lymphoma (B-NHL) have an excellent chance of survival,
however, current clinical risk stratification places as many as half of patients in a high-risk …
however, current clinical risk stratification places as many as half of patients in a high-risk …